9/12/2011. Conflicts of Interest. Endocarditis. Last Chance Pharmacotherapy Review Webinar Infectious Diseases September 7, Causative organisms
|
|
- Tyrone Lewis
- 5 years ago
- Views:
Transcription
1 Conflicts of Interest I have no conflicts to disclose. Last Chance Pharmacotherapy Review Webinar Infectious Diseases September 7, 2011 Endocarditis Endocarditis Causative organisms Other C. albicans Coag-neg Staph Enterococci S. aureus Streptococci Viridans Streptococci penicillin G (± gentamicin) ceftriaxone (± gentamicin) vancomycin * treatment is for 2-4 weeks (gentamicin allows for shorter course of therapy) * treatment is for 6 weeks with prosthetic valve Enterococci penicillin G or ampicillin plus streptomycin or gentamicin vancomycin plus streptomycin or gentamicin * treatment is for 4-6 weeks * treatment is for 6 weeks in prosthetic valves * streptomycin or gentamicin must be given due to inherent resistance Endocarditis Surgical Prophylaxis Methicillin sensitive S. aureus oxacillin or nafcillin (± gentamicin) cefazolin (± gentamicin) vancomycin * treatment is for 6 weeks (gentamicin for 3-5 days decreases bacterial load) * treatment is for 6 weeks plus gentamicin for 2 weeks in prosthetic valves also add rifampin Methicillin resistant S. aureus vancomycin daptomycin * treatment is for 6 weeks * treatment is for 6 weeks plus gentamicin for 2 weeks in prosthetic valves also add rifampin Gastric/duodenal Indicated for morbid obesity, esophageal obstruction, gastric acidity, or GI motility cefazolin 1 2 g preinduction Biliary Acute cholecystitis, obstructive jaundice, CD stones, age > 70 cefazolin [or cefoxitin] 1 2 g preinduction Appendectomy cefoxitin 1 2 g [or cefazolin plus metronidazole or ampicillin/sulbactam] preinduction Colorectal Cefoxitin or cefotetan 1 2 g [or cefazolin plus metronidazole or ampicillin/sulbactam or ertapenem] preinduction OR gentamicin/ tobramycin 1.5 mg/kg and clindamycin 600 mg/metronidazole g preinduction ± neomycin 1 g and erythromycin 1 g at 19, 18, and 9 hours before surgery or neomycin 2 g and metronidazole 2 g at 13 and 9 hours before surgery 1
2 Surgical Prophylaxis Pneumonia Vaginal/abdominal hysterectomy cefazolin or cefoxitin or cefotetan 1 2 g [or ampicillin/sulbactam] preinduction Cesarean section cefazolin 1-2 g after the cord is clamped Oth Orthopedic (surgery involves prosthetic materials) cefazolin 1-2 g preinduction [or cefuroxime or vancomycin] Head and Neck (incision thru oral or pharyngeal mucosa) cefazolin 1 2 g or ampicillin / sulbactam g or gentamicin 1.5 mg/kg and clindamycin mg preinduction Cardiac surgery cefazolin or cefuroxime 1 2 g preinduction (+ intraoperative doses); if MRSA is probable or patient has been hospitalized, then vancomycin Pulmonary resection (i.e., lobectomy and pneumonectomy) cefazolin or cefuroxime 1 2 g preinduction [or vancomycin] Vascular surgery cefazolin 1 g preinduction and every 8 hours for 3 doses; if MRSA is probable, then use vancomycin. Definitions CAP - no hospital or LTC facility for past 14 days HAP - 48 hours or more after admission VAP - more than hours after endotracheal intubation HCAP hospitalized in past 90 days; resides in NH or LTC; IV antibiotic therapy, chemotherapy, or wound care in past 30 days; attends hospital or HD clinic CURB-65 RR >= 30 DBP <=60 or SBP < 90 BUN > 19 Confusion Age >= 65 CURB-65 score 0 or 1 = home treatment 2 = consider hospital = 3 hospital Pneumonia - Community CAP Outpatient Therapy CAP Inpatient Therapy Healthy / No abx in 3 mos Moderate Fluoroquinolone Macrolide Macrolide plus 3rd Doxycycline generation cephalosporin Comorbidities / Abx in 3 mos or ampicillin or ertapenem Fluoroquinolone Macrolide (or doxycycline) Severe Ampicillin/sulbactam plus with high-dose amoxicillin (1g a respiratory FQ or TID) or azithromycin amoxicillin/clavulanate (2g 3rd gen cephalosporin BID) or cephalosporin (ceftriaxone, cefuroxime, plus a respiratory FQ or azithromycin cefpodoxime) May need broader antibacterial activity Pneumonia - Nosocomial Nosocomial Therapy Early onset and no MDR 3rd-generation ceph Fluoroquinolone Ampicillin-sulbactam Ertapenem Late onset or MDR Ceftazidime or cefepime or imipenem or meropenem or doripenem or piperacillintazobactam plus aminoglycoside or fluoroquinolone Vancomycin or linezolid if MRSA is suspected Risk factors for MDR organisms Antibiotic therapy < 90 days Hospitalization ti 5d days High local resistance Risk factors for HCAP Immunosuppressive disease and/or therapy Case Vignette 1 - ID Question 1-A TP is a 56-year-old male who presents with increasing malaise and fevers that have occurred over the past few weeks. His weakness is now affecting his activities of daily living. He is occasionally short of breath. PMH: COPD, hypertension, BPH, mitral valve prolapse with regurgitation and generalized anxiety disorder. He is a past 2 pack per day smoker, but quit 5 years ago. Medications on admission include: sertraline 100mg po daily, tamsulosin 0.4mg po daily, tiotropium i inhalation daily, and lisinopril 40mg po daily. TP develops a rash when receiving penicillins. On physical exam TP has an extensive systolic ejection murmur. He is afebrile. Labs: Na 143, K 4.2, Cl 102, HCO3 22, BUN 28, Scr 1.43 and glucose 134, Hgb 10.2, Hct 30.8, WBC 12.2 and platelets 220. Three of 3 blood cultures: gram positive cocci in chains. Echo: large vegetation on his mitral valve and an ejection fraction of 56%. His cultures ultimately grow Streptococci mitis (one of the viridans group of Streptococci) that is highly sensitive to penicillin. What is the best therapy for TP? 1. Penicillin G 2 million units every 4 hours for 4 weeks plus gentamicin 1 mg/kg IV q12h for the first 5 days. 2. Cefazolin 1g IV q8h plus gentamicin 1mg/kg IV q12h for 6 weeks. 3. Ceftriaxone 2g IV daily plus gentamicin 1mg/kg IV q12h for 2 weeks. 4. Vancomycin 15mg/kg IV q24h for 2 weeks. 2
3 Reevaluate Case 1-A - ID Question RE1-A DL is a 38 year old male with a history of IV drug use who presents with fever and chills. Blood cultures are drawn and all are positive for Gram positive cocci in chains, ultimately identified ed as Enterococcus faecalis. He is started on ampicillin and gentamicin. In this situation the best reason for using gentamicin is that it: 1. allows for a shortened length of therapy. 2. has a necessary synergistic effect since no single antibiotic is bactericidal against Enterococcus. 3. has activity against Gram negative organisms, which frequently co-infect valves in patients with Enterococcal endocarditis. 4. lessens the bacterial load and quickens the time to defervescence. Case Vignette 1 - ID Question 1-B TP completes his therapy but 6 weeks later he continues to have problems with shortness of breath and further development of heart failure. It is decided ded that he will need a mitral valve replacement. Surgery is scheduled. For TP, undergoing open heart surgery, which is the best recommendation for his perioperative antibiotics? 1. Vancomycin 1g IV within one hour of surgery andupto24hoursafter after. 2. Cefazolin 1g IV within one hour of surgery and every 8 hours for 72 hours after surgery. 3. Cefazolin 1g IV within one hour of surgery and up to 24 hours after. 4. Ceftriaxone 1g IV within one hour of surgery, and 1g IV after surgery. Reevaluate Case 1-B - ID Question RE1-B You are developing a table of appropriate antibiotic choices for surgical prophylaxis at your local hospital. For which one of the following procedures would cefazolin alone not be the best antibiotic to use? 1. Vaginal hysterectomy 2. Total hip replacement in a patient who develops a rash with ampicillin 3. Biliary surgery in a patient with common duct stones 4. Colorectal surgery in a patient who develops diarrhea with penicillin 3
4 Case Vignette 1 - ID Question 1-C Following surgery TP recovers in the intensive care unit and is mechanically ventilated. On the third day of hospitalization/intensive care unit stay, TP develops e a fever e and localized infiltrates on chest x-ray. He is also producing copious, thick sputum. Vital signs: temperature: F, HR 78, RR vented, BP 134/86. Labs: Na 136, K 4.8, Cl 98, HCO3 23, BUN 24, Scr 0.92 and glucose 110, Hgb 9.6, Hct 28.5, WBC 18.6 and platelets 335. What is the best empiric treatment for TP? 1. Ceftriaxone 1g IV daily plus azithromycin 500mg IV daily. 2. Ceftriaxone 1g IV daily plus levofloxacin 750mg IV daily plus linezolid 600mg IV q12h. 3. Cefepime 1g IV q12h plus tobramycin 7 mg/kg IV q24h plus linezolid 600mg IV q12h. 4. Piperacillin/tazobactam 4.5g IV q6h plus tigecycline 50mg IV q12h plus vancomycin 15 mg/kg IV q12h Reevaluate Case 1-C - ID Question RE1-C JW is a 66-year-old female who presents to the emergency department with extreme shortness of breath, cough with productive sputum and confusion. PMH: diabetes, hypertension and osteoporosis. She does not smoke. Medications on admission include: metformin 1000mg po BID, glyburide 5mg po daily, lisinopril 40 mg po daily, hydrochlorothiazide 12.5 mg po daily and alendronate 70mg weekly. JW lives at home with her husband and has had no antibiotics for at least 3 years. JW is allergic to morphine and sulfa antibiotics. On physical exam: temperature of 102.4F, HR 95 bpm, RR of 31 bpm and BP of 86/62. Labs: Na 147, K 3.7, Cl 101, HCO3 19, BUN 36, Scr 1.22 and glucose 144, Hgb 11.2, Hct, 34.8, WBC 18.4 and platelets 333. What is the best treatment for JW? 1. Send her home with a prescription for doxycycline 100mg po twice daily for 10 days. 2. Admit her to the hospital, to a general medicine floor, and start on ceftriaxone 1g IV daily plus clarithromycin 500mg po twice daily for at least 5 days. 3. Admit her to the hospital, to an intermediate care unit and start on levofloxacin 750mg IV daily for at least 10 days. 4. Admit her to the hospital to an intensive care unit and start on ceftriaxone 1g IV daily plus azithromycin 500mg IV daily for at least 5 days. Case Vignette 1 - ID Question 1-D TPs sputum eventually grows Klebsiella pneumoniae. Sensitivities are typical for K. pneumoniae and it is not a multi drug resistant organism. oga TPs therapy is best refined to: 1. Linezolid 600mg IV q12h with treatment for a total of 8 days. 2. Cefepime 1g IV q12h with treatment for a total of 8 days. 3. Tigecycline 50mg IV q12h with treatment for a total of 14 days. 4. Piperacillin/tazobactam 4.5g IV q6h with treatment for a total of 14 days. 4
5 Question RE1-D Of the following scenarios, which patient demonstrates the best case for starting vancomycin or linezolid empirically? 1. A patient with CAP who has comorbidities (CHF and diabetes) but no recent antibiotic use. 2. A patient who develops pneumonia on day 6 of his stay in an ICU, but has not had antibiotics in more than 5 years. 3. A patient hospitalized for trauma who develops a pneumonia on day 3 of hospitalization in the ICU. 4. A patient with a CURB-65 score of 2, who is hospitalized for pneumonia, lives at home and had a week s worth of oral antibiotics 6 weeks ago. Urinary Tract Infections Community Factors - complicated UTIs: Male sex K. pneumoniae P. mirabilis S. saprophyticus Enterococcus Hospital-acquired Pregnancy Anatomical abnormality E. coli Childhood UTI Nosocomial Recent antimicrobial use Fungi Diabetes Enterococcus Indwelling urinary catheter P. mirabilis Recent UT instrumentation S. aureus Immunosuppression E. coli K. pneumoniae P. aeruginosa Other Gram-negative Urinary Tract Infections Tuberculosis Uncomplicated cystitis TMP/SMZ (3 days) Nitrofurantoin (5 days) Fosfomycin (1 dose) Alternatives: Fluoroquinolone l (3 days) Beta lactams (3-7 days) Pregnancy (7 days) Amoxicillin Nitrofurantoin Cephalexin TMP/SMZ Uncomplicated pyelonephritis* Fluoroquinolone (5-7 days) TMP/SMZ (14 days) Beta lactam (10-14 days) Complicated UTIs (5-14 days) Fluoroquinolone Aminoglycoside Extended spectrum beta lactam HIV-negative patients: INH + RIF + PZA + EMB for 2 months (daily, 5x/week, TIW or BIW) then INH + RIF for 4 more months (daily, 5x/week, TIW, or BIW) INH + RIF + EMB for 2 months (daily or 5x/week) then INH + RIF for 7 more months (daily, 5x/week or BIW) HIV-positive patients: INH + RIF + PZA + EMB for 2 months (daily, 5x/week or TIW) then INH + RIF for 4 more months (daily, 5x/week or TIW) INH + RIF + EMB for 2 months (daily or 5x/week) then INH + RIF for 7 more months (daily or 5x/week) * If uropathogen resistance > 10% use initial dose of long acting beta lactam or once daily aminoglycoside Case Vignette 2 - ID Question 2-A HT is a 25-year-old female who presents to the clinic with a 3 day history of burning on urination and pain in her lower back. She has not taken her temperature at home but has felt warm over the past 24 hours. PMH: partial complex seizures. Recently she has also had cough with minimal sputum production, that won t go away. She smokes ½ pack of cigarettes daily and immigrated to the US from Laos 11 years ago. HT has NKDA and is taking Ortho Novum 7/7/7 daily and valproic acid 250mg po TID. On physical exam HT continues to complain of back pain. Her temperature is 100.5F. Labs: Na 138, K 4.1, Cl 97, HCO3 25, BUN 18, Scr 1.07 and glucose 99, Hgb 12.2, Hct, 36.2, WBC 14.2 and platelets 195. Her valproic acid concentration is 82 mg/l. A urinalysis is completed which shows turbidity, neg. glucose; ph 5.4; protein 0 mg/dl; WBCs; + nitrites; 8-10 red blood cells (RBCs); many bacteria and +casts. Urine cultures are obtained but no results are back. The best treatment for HT s infection is: 1. Trimethoprim/sulfamethoxazole DS po q12h for 14 days of therapy 2. Levofloxacin 500mg gpo daily for 3 days of therapy 3. Azithromycin 500mg po x1, then 250mg po daily for 5 total days of therapy 4. Nitrofurantoin 100mg po BID for 5 days of therapy 5
6 Reevaluate Case 2-A - ID Question RE2-A RM is a 56-year-old female who presents to the clinic with a 5 day history of burning on urination and urgency. She is afebrile. PMH: diabetes and severe rheumatoid arthritis. RM has NKDA and is taking metformin 500mg po BID, insulin glargine 20 units SC at bedtime, methotrexate 15mg po weekly and prednisone 10mg po daily. RM has no specific complaints. Her temperature is 98.5F. Urinalysis: turbidity, pos. glucose; ph 5.8; protein 0 mg/dl; WBCs; + nitrites; 0 red blood cells (RBCs); many bacteria and no casts. Urine cultures are obtained but no results are back. The best treatment for RM s infection is: 1. Trimethoprim/sulfamethoxazole DS po q12h for 14 days of therapy 2. Levofloxacin 750mg po daily for 5 days of therapy 3. Gentamicin 5 mg/kg IV daily for 3 days of therapy 4. Cefazolin 1g IV q8h for 7 days Case Vignette 2 - ID Question 2-B During the clinic visit HT is scheduled for a follow up to assess her chronic cough. A sputum culture is sent and a chest x-ray is taken. ae On ces chest x-ray, HT has infiltrates in her right upper lobe and her sputum smear is positive for acid-fast bacilli. If HT s cough is treated with appropriate antibiotics, based on the sputum results, what would most likely happen to HT if no changes occurred in her current drug therapy: 1. An increase in weight gain and breast tenderness. 2. An increase in somnolence. 3. An increase in seizure frequency. 4. An increase in acne. Reevaluate Case 2-B - ID Question RE2-B ML is a 38 year old male with a history of recent exposure to two patients with tuberculosis. He develops a cough with a low grade fever, frequent night sweats s and a 10 pound weight loss. In the emergency department a sputum sample is taken and ML is admitted. The sputum is positive for acid fast bacilli. What is the best empiric regimen for ML? 1. Rifampin plus isoniazid for 6 months. 2. Rifampin plus isoniazid plus ethambutol for 2 months, followed by rifampin plus isoniazid for 4 months. 3. Rifampin plus isoniazid plus ethambutol plus pyrazinamide for 2 months followed by rifampin plus isoniazid for 4 months. 4. Rifampin plus isoniazid plus ethambutol plus pyrazinamide for 6 months. 6
7 Cellulitis Immunizations - Adult Acute cellulitis (S. pyogenes, S. aureus) 5 10 days Anti-staphylococcal PCN Penicillin G (if strep) Clindamycin -lactamase inhibitor combinations 1 st generation cephalosporin Vancomycin or linezolid Erysipelas (S. pyogenes) 7 10 days Penicillin G Clindamycin Necrotizing fasciitis (Streptococcal, Mixed - includes anaerobes) Surgical debridement -lactamase inhibitor combinations plus clindamycin plus ciprofloxacin i Carbapenems Cefotaxime plus clindamycin or metronidazole Streptococcal necrotizing fasciitis: high-dose IV penicillin plus clindamycin Immunizations - Adult Case Vignette 3 - ID SD is a 69-year-old male who presents to the ED with a 2 day history of redness and swelling of his right thigh. A week ago he sustained a significant abrasion to the thigh from an accident involving a power sander. Although the abrasion was initially healing, over the past few days the area around the injury has become red and warm to the touch, and the redness appears to be spreading. PMH: bipolar disorder, atrial fibrillation, hypertension, and osteoarthritis. SD is taking lamotrigine 100mg po daily, bupropion SR 150mg po BID, warfarin 3mg po daily, diltiazem CD 240mg po daily, and acetaminophen 500mg po prn. SD has NKDA. On physical exam SD has an area of redness about 4.5cm in diameter, around a recent abrasion. The area is warm to the touch but is not raised. The right thigh circumference is greater than the left thigh. His temperature is 102.4F. Labs: Na 148, K 4.6, Cl 100, HCO3 23, BUN 12, Scr 0.89 and glucose 88, Hgb 13.4, Hct 40.2, WBC 12.2 and platelets 344. SD is admitted to the hospital for treatment. Question 3-A The best treatment for SD s infection is: 1. Trimethoprim/sulfamethoxazole 5 mg/kg of TMP IV q12h followed by i DS BID for 7 days total 2. Clindamycin 900mg IV q8h followed by 300mg po QID for 10 days total 3. Piperacillin/tazobactam 3.375g IV q8h for 5 days total 4. Linezolid 600mg po q12h for 14 days Reevaluate Case 3-A - ID PL is a 44-year-old male with diabetes who presents to the emergency department with a 4 day history of scrotal redness and swelling. The area adjacent to the scrotum is also red and warm to the touch. He is diagnosed with Fournier s gangrene, a type of necrotizing fasciitis. PL is taken to surgery for debridement and started on antibiotics. 7
8 Question RE3-A Case Vignette 3 - ID The best empiric therapy for PL is: 1. Nafcillin 2g IV q4h 2. Vancomycin 15mg/kg IV q12h plus clindamycin 900mg IV q8h 3. Doripenem 500mg IV q8h 4. Penicillin G 2 million units q6h plus metronidazole 500mg IV q8h SD is questioned about his vaccine use. He has received the flu vaccine off and on over the past 10 years, but has received no other vaccinations. a Question 3-B Reevaluate Case 3-B - ID Which of the following is the best combination of vaccinations for SD? 1. Influenza, pneumococcal polysaccharide, Tdap booster, zoster 2. Influenza, meningococcal, Td booster, hepatitis B 3. Influenza, pneumococcal polysaccharide, measles-mumps-rubella booster, zoster 4. Influenza, hepatitis A, hepatitis B, Tdap booster Five patients come to your clinic: LP a 4-year-old female with sickle cell disease SS a 36-year-old male with hypertension, hyperlipidemia p and hypothyroidism y TM a 62-year-old female with osteoarthritis, seasonal allergies and GERD WA a 48-year-old male with diabetes mellitus, peripheral neuropathy and sinusitis RG a 27-year-old female with migraines and depression, who smokes ½ pack per day Question RE3-B Extra Question Case 1 - ID Vaccinating which of the following groups would best protect all the patients that should receive the pneumococcal polysaccharide vaccine? 1. LP, SS and TM 2. LP and WA 3. LP, WA, and RG 4. SS, TM and RG LA is a 28-year-old female who has had three urinary tract infections in the past 7 months. She presents to the clinic once again with dysuria, urgency and frequency. The UTIs do not appear to be associated with sexual activity. 8
9 Extra Question 1 - ID Extra Question Case 2 - ID Following appropriate treatment for this UTI, what is the best therapy to offer LA? 1. Nothing. She should call her physician when she experiences symptoms again. 2. A prescription for trimethoprim/sulfamethoxazole, which she should initiate on her own at the first sign of another UTI. 3. A prescription for trimethoprim/sulfamethoxazole single strength to take once daily to prevent another UTI. 4. A prescription for trimethoprim/sulfamethoxazole single strength to take after sexual intercourse. CF is a 59-year-old male with type 2 diabetes mellitus. His diabetes is poorly controlled and he now has peripheral neuropathy and stage 3 chronic c kidney disease (CrCl C 35 ml/min). He comes to the emergency department with a red, swollen, left foot. The redness has increased over the past few days. A small ulcer has begun to form on the bottom of his left foot. He has had no antibiotics for many years. Extra Question 2 - ID Extra Question Case 3 - ID What is the best treatment for CF? 1. Levofloxacin 750mg IV every 48 hours and clindamycin 900mg IV q8h 2. Ampicillin/sulbactam 3g IV q8h. 3. Azithromycin 500mg IV daily 4. Cefazolin 1g IV q8h MW is a 45-year-old male who was admitted to the ICU following a motorcycle versus deer accident. He only has a history of hypertension for which he takes lisinopril. On day 3 of hospitalization he spikes a temperature and his WBC count increases to He has some new markings on his chest X-ray as well. Extra Question 3 - ID Extra Question Case 4 - ID What is the best empiric treatment for MW? 1. Doripenem 500mg IV q8h plus vancomycin 15 mg/kg IV q12h for 14 days 2. Cefepime 1g IV q12h plus tobramycin 7 mg/kg IV daily plus linezolid 600mg IV q12h for 14 days 3. Piperacillin/tazobactam 4.5g IV q6h for 8 days 4. Ceftriaxone 1g IV daily for 7-8 days. NL is scheduled to have a dental procedure (root canal) performed next week. She has a history of congenital heart disease. She is allergic aegcope to penicillin (as) (rash). 9
10 Extra Question 4 - ID Extra Question Case 5 - ID What is the best recommendation for endocarditis prophylaxis in NL? 1. No prophylaxis is required 2. Clarithromycin 500mg, one hour before procedure 3. Amoxicillin 2g, one hour before procedure 4. Clindamycin 600mg, one hour before and six hours after procedure RB is a 69-year-old male who presents to the emergency department with a 4 day history of fever, chills, frequency, urgency and perineal pain. A urinalysis s is completed ed and found to have many bacteria. A rectal exam is completed and RB is found to have a swollen, tender prostate. He is diagnosed with acute bacterial prostatitis. Extra Question 5 - ID Your recommendation for the best therapy, including duration, for RB is: 1. Trimethoprim/sulfamethoxazole DS po BID for 7 days. 2. Amoxicillin/clavulanate 875 po BID for 14 days 3. Cefpodoxime 200mg po BID for 21 days 4. Ciprofloxacin 500mg po BID for 28 days 10
Perichondritis: Source: UpToDate Ciprofloxacin 10 mg/kg/dose PO (max 500 mg/dose) BID Inpatient: Ceftazidime 50 mg/kg/dose q8 hours IV
Empiric Antibiotics for Pediatric Infections Seen in ED NOTE: Choice of empiric antibiotic therapy must take into account local pathogen frequency and resistance patterns, individual patient characteristics,
More informationAntibiotic Abyss. Discussion Points. MRSA Treatment Guidelines
Antibiotic Abyss Fredrick M. Abrahamian, D.O., FACEP, FIDSA Professor of Medicine UCLA School of Medicine Director of Education Department of Emergency Medicine Olive View-UCLA Medical Center Sylmar, California
More information10/13/14. Low: not well absorbed. Good: [blood and tissue] < than if given IV. High: > 90% absorption orally
Low: not well absorbed PO agent not for serious infection nitrofurantoin Good: [blood and tissue] < than if given IV [Therapeutic] in excess of [effective] eg. cephalexin High: > 90% absorption orally
More informationVCH PHC SURGICAL PROPHYLAXIS RECOMMENDATIONS
VCH PHC SURGICAL PROPHYLAXIS RECOMMENDATIONS CARDIAC Staphylococcus aureus, S. epidermidis, except for For patients with known MRSA colonization, recommend decolonization with Antimicrobial Photodynamic
More informationAntibiotic Updates: Part II
Antibiotic Updates: Part II Fredrick M. Abrahamian, DO, FACEP, FIDSA Health Sciences Clinical Professor of Emergency Medicine David Geffen School of Medicine at UCLA Los Angeles, California Financial Disclosures
More information1. The preferred treatment option for an initial UTI episode in a 22-year-old female patient
1 Chapter 79, Self-Assessment Questions 1. The preferred treatment option for an initial UTI episode in a 22-year-old female patient with normal renal function is: A. Trimethoprim-sulfamethoxazole B. Cefuroxime
More information2015 Updates in Therapeutics: The Pharmacotherapy Preparatory Review & Recertification Course Infectious Diseases Curtis L. Smith, Pharm.D.
2015 Updates in Therapeutics: The Pharmacotherapy Preparatory Review & Recertification Course Infectious Diseases Curtis L. Smith, Pharm.D., BCPS Ferris State University Conflict of Interest Disclosures
More information21 st Expert Committee on Selection and Use of Essential Medicines Peer Review Report Antibiotics Review
(1) Have all important studies/evidence of which you are aware been included in the application? Yes No Please provide brief comments on any relevant studies that have not been included: (2) For each of
More informationGeneral Approach to Infectious Diseases
General Approach to Infectious Diseases 2 The pharmacotherapy of infectious diseases is unique. To treat most diseases with drugs, we give drugs that have some desired pharmacologic action at some receptor
More informationMercy Medical Center Des Moines, Iowa Department of Pathology. Microbiology Department Antibiotic Susceptibility January December 2016
Mercy Medical Center Des Moines, Iowa Department of Pathology Microbiology Department Antibiotic Susceptibility January December 2016 These statistics are intended solely as a GUIDE to choosing appropriate
More information2016 Antibiotic Susceptibility Report
Fairview Northland Medical Center and Elk River, Milaca, Princeton and Zimmerman Clinics 2016 Antibiotic Susceptibility Report GRAM-NEGATIVE ORGANISMS 2016 Gram-Negative Non-Urine The number of isolates
More information2015 Antibiotic Susceptibility Report
Citrobacter freundii Enterobacter aerogenes Enterobacter cloacae Escherichia coli Haemophilus influenzenza Klebsiella oxytoca Klebsiella pneumoniae Proteus mirabilis Pseudomonas aeruginosa Serratia marcescens
More informationCLINICAL USE OF BETA-LACTAMS
CLINICAL USE OF BETA-LACTAMS Douglas Black, Pharm.D. Associate Professor School of Pharmacy University of Washington dblack@u.washington.edu WHY IS INFECTIOUS DISEASE PHARMACOTHERAPY SO CONFUSING? Microbial
More informationHead to Toe: Common infections in Hospital settings. Katya Calvo MD Medical Director of Antimicrobial Stewardship Division of Infectious Diseases
Head to Toe: Common infections in Hospital settings Katya Calvo MD Medical Director of Antimicrobial Stewardship Division of Infectious Diseases Objectives To identify at least one common infection in
More informationChildrens Hospital Antibiogram for 2012 (Based on data from 2011)
Childrens Hospital Antibiogram for 2012 (Based on data from 2011) Prepared by: Department of Clinical Microbiology, Health Sciences Centre For further information contact: Andrew Walkty, MD, FRCPC Medical
More informationPrinciples of Infectious Disease. Dr. Ezra Levy CSUHS PA Program
Principles of Infectious Disease Dr. Ezra Levy CSUHS PA Program I. Microbiology (1) morphology (e.g., cocci, bacilli) (2) growth characteristics (e.g., aerobic vs anaerobic) (3) other qualities (e.g.,
More informationGuidelines for Treatment of Urinary Tract Infections
Guidelines for Treatment of Urinary Tract Infections Overview This document details the Michigan Hospital Medicine Safety (HMS) Consortium preferred antibiotic choices for treatment of uncomplicated and
More informationAntimicrobial Susceptibility Patterns
Antimicrobial Susceptibility Patterns KNH SURGERY Department Masika M.M. Department of Medical Microbiology, UoN Medicines & Therapeutics Committee, KNH Outline Methodology Overall KNH data Surgery department
More informationApproach to pediatric Antibiotics
Approach to pediatric Antibiotics Gassem Gohal FAAP FRCPC Assistant professor of Pediatrics objectives To be familiar with common pediatric antibiotics o Classification o Action o Adverse effect To discus
More informationGENERAL NOTES: 2016 site of infection type of organism location of the patient
GENERAL NOTES: This is a summary of the antibiotic sensitivity profile of clinical isolates recovered at AIIMS Bhopal Hospital during the year 2016. However, for organisms in which < 30 isolates were recovered
More informationAntimicrobial Update. Alison MacDonald Area Antimicrobial Pharmacist NHS Highland April 2018
Antimicrobial Update Alison MacDonald Area Antimicrobial Pharmacist NHS Highland alisonc.macdonald@nhs.net April 2018 Starter Questions Setting the scene... What if antibiotics were no longer effective?
More informationAberdeen Hospital. Antibiotic Susceptibility Patterns For Commonly Isolated Organisms For 2015
Aberdeen Hospital Antibiotic Susceptibility Patterns For Commonly Isolated s For 2015 Services Laboratory Microbiology Department Aberdeen Hospital Nova Scotia Health Authority 835 East River Road New
More information* gender factor (male=1, female=0.85)
Usual Doses of Antimicrobials Typically Not Requiring Renal Adjustment Azithromycin 250 500 mg Q24 *Amphotericin B 1 3-5 mg/kg Q24 Clindamycin 600 900 mg Q8 Liposomal (Ambisome ) Doxycycline 100 mg Q12
More informationAntimicrobial Susceptibility Testing: Advanced Course
Antimicrobial Susceptibility Testing: Advanced Course Cascade Reporting Cascade Reporting I. Selecting Antimicrobial Agents for Testing and Reporting Selection of the most appropriate antimicrobials to
More informationRational management of community acquired infections
Rational management of community acquired infections Dr Tanu Singhal MD, MSc Consultant Pediatrics and Infectious Disease Kokilaben Dhirubhai Ambani Hospital, Mumbai Why is rational management needed?
More informationPRACTIC GUIDELINES for APPROPRIATE ANTIBIOTICS USE
PRACTIC GUIDELINES for APPROPRIATE ANTIBIOTICS USE Global Alliance for Infection in Surgery World Society of Emergency Surgery (WSES) and not only!! Aims - 1 Rationalize the risk of antibiotics overuse
More informationGUIDELINES FOR THE MANAGEMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN ADULTS
Version 3.1 GUIDELINES FOR THE MANAGEMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN ADULTS Date ratified June 2008 Updated March 2009 Review date June 2010 Ratified by Authors Consultation Evidence base Changes
More informationAppropriate Management of Common Pediatric Infections. Blaise L. Congeni M.D. Akron Children s Hospital Division of Pediatric Infectious Diseases
Appropriate Management of Common Pediatric Infections Blaise L. Congeni M.D. Akron Children s Hospital Division of Pediatric Infectious Diseases It s all about the microorganism The common pathogens Viruses
More information11/10/2016. Skin and Soft Tissue Infections. Disclosures. Educational Need/Practice Gap. Objectives. Case #1
Disclosures Selecting Antimicrobials for Common Infections in Children FMR-Contemporary Pediatrics 11/2016 Sean McTigue, MD Assistant Professor of Pediatrics, Pediatric Infectious Diseases Medical Director
More informationAminoglycosides. Spectrum includes many aerobic Gram-negative and some Gram-positive bacteria.
Aminoglycosides The only bactericidal protein synthesis inhibitors. They bind to the ribosomal 30S subunit. Inhibit initiation of peptide synthesis and cause misreading of the genetic code. Streptomycin
More informationAntimicrobial Stewardship in the Long Term Care and Outpatient Settings. Carlos Reyes Sacin, MD, AAHIVS
Antimicrobial Stewardship in the Long Term Care and Outpatient Settings Carlos Reyes Sacin, MD, AAHIVS Disclosure Speaker and consultant in HIV medicine for Gilead and Jansen Pharmaceuticals Objectives
More informationAntibiotic Stewardship Program (ASP) CHRISTUS SETX
Antibiotic Stewardship Program (ASP) CHRISTUS SETX Program Goals I. Judicious use of antibiotics Decrease use of broad spectrum antibiotics and deescalate use based on clinical symptoms Therapeutic duplication:
More informationThe β- Lactam Antibiotics. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018
The β- Lactam Antibiotics Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018 Penicillins. Cephalosporins. Carbapenems. Monobactams. The β- Lactam Antibiotics 2 3 How
More informationInteractive session: adapting to antibiogram. Thong Phe Heng Vengchhun Felix Leclerc Erika Vlieghe
Interactive session: adapting to antibiogram Thong Phe Heng Vengchhun Felix Leclerc Erika Vlieghe Case 1 63 y old woman Dx: urosepsis? After 2 d: intermediate result: Gram-negative bacilli Empiric antibiotic
More informationAdvanced Practice Education Associates. Antibiotics
Advanced Practice Education Associates Antibiotics Overview Difference between Gram Positive(+), Gram Negative(-) organisms Beta lactam ring, allergies Antimicrobial Spectra of Antibiotic Classes 78 Copyright
More informationAntimicrobial Therapy
Antimicrobial Therapy David H. Spach, MD Professor of Medicine Division of Infectious Diseases University of Washington, Seattle Disclosure: Dr. Spach has no significant financial interest in any of the
More informationCase 2 Synergy satellite event: Good morning pharmacists! Case studies on antimicrobial resistance
Case 2 Synergy satellite event: Good morning pharmacists! Case studies on antimicrobial resistance 22nd Congress of the EAHP "Hospital pharmacists catalysts for change", 22-24 March 2017, Cannes Disclosure
More informationEUCAST recommended strains for internal quality control
EUCAST recommended strains for internal quality control Escherichia coli Pseudomonas aeruginosa Staphylococcus aureus Enterococcus faecalis Streptococcus pneumoniae Haemophilus influenzae ATCC 59 ATCC
More informationAntibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting
Antibiotic Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting Any substance of natural, synthetic or semisynthetic origin which at low concentrations kills or inhibits the growth of bacteria
More informationUpdate on Fluoroquinolones. Charles Krasner, M.D. June 16, 2016 Antibiotic Stewardship Program -ECHO
Update on Fluoroquinolones Charles Krasner, M.D. June 16, 2016 Antibiotic Stewardship Program -ECHO Potential fluoroquinolone side-effects Increased risk, greater than with most other antibiotics, for
More informationInfectious Disease 101: Helping the Consultant Pharmacist with Stewardship Principles
Infectious Disease 101: Helping the Consultant Pharmacist with Stewardship Principles Conflicts of Interest None at this time May be discussing off-label indications KALIN M. CLIFFORD, PHARM.D., BCPS,
More information3/23/2017. Kathryn G. Smith, PharmD PGY1 Pharmacy Resident Via Christi Hospitals Wichita, Inc. Kathryn G. Smith: Nothing to disclose
Kathryn G. Smith, PharmD PGY1 Pharmacy Resident Via Christi Hospitals Wichita, Inc Kathryn G. Smith: Nothing to disclose Describe the new updates and rationale for them Relay safety concerns with use of
More informationGuidelines for the Initiation of Empirical Antibiotic therapy in Respiratory Disease (Adults)
Guidelines for the Initiation of Empirical Antibiotic therapy in Respiratory Disease (Adults) Community Acquired Community Acquired 1) Is it pneumonia? ie new symptoms and signs of a lower respiratory
More informationTable 1. Commonly encountered or important organisms and their usual antimicrobial susceptibilities.
Table 1. Commonly encountered or important organisms and their usual antimicrobial susceptibilities. Gram-positive cocci: Staphylococcus aureus: *Resistance to penicillin is almost universal. Resistance
More informationAntimicrobial Chemotherapy
2016 edition by Claudine El-Beyrouty, PharmD, BCPS Department of Pharmacy Thomas Jefferson University Hospital Brian Roslund, PharmD, BCPS, AQ-ID Department of Pharmacy Thomas Jefferson University Hospital
More informationDiscussion Points. Decisions in Selecting Antibiotics
Antibiotics in Acute Care Fredrick M. Abrahamian, D.O., FACEP, FIDSA Clinical Professor of Medicine UCLA School of Medicine Director of Education Department of Emergency Medicine Olive View-UCLA Medical
More informationHelp with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST
Help with moving disc diffusion methods from BSAC to EUCAST This document sets out the main differences between the BSAC and EUCAST disc diffusion methods with specific emphasis on preparation prior to
More informationAntimicrobial Stewardship
Antimicrobial Stewardship Antimicrobial Stewardship Studies have estimated that 30 50% of antibiotics prescribed in acutecare hospitals are unnecessary or inappropriate 1 Antimicrobial stewardship definition:
More informationAntibiotic Updates: Part I
Antibiotic Updates: Part I Fredrick M. Abrahamian, DO, FACEP, FIDSA Health Sciences Clinical Professor of Emergency Medicine David Geffen School of Medicine at UCLA Los Angeles, California Financial Disclosures
More informationOther Beta - lactam Antibiotics
Other Beta - lactam Antibiotics Assistant Professor Dr. Naza M. Ali Lec 5 8 Nov 2017 Lecture outlines Other beta lactam antibiotics Other inhibitors of cell wall synthesis Other beta-lactam Antibiotics
More informationAppropriate antimicrobial therapy in HAP: What does this mean?
Appropriate antimicrobial therapy in HAP: What does this mean? Jaehee Lee, M.D. Kyungpook National University Hospital, Korea KNUH since 1907 Presentation outline Empiric antimicrobial choice: right spectrum,
More informationBad Bugs. Pharmacist Learning Objectives. Antimicrobial Resistance. Patient Case. Pharmacy Technician Learning Objectives 4/8/2016
Pharmacist Learning Objectives Antimicrobial Resistance Julie Giddens Pharm D, BCPS Infectious Disease Clinical Pharmacist OSF Saint Francis Medical Center Peoria, IL The speaker has no conflicts to disclose
More informationUTI Dr S Mathijs Department of Pharmacology
UTI Dr S Mathijs Department of Pharmacology Introduction Responsible for > 7 million consultations annually 15% of all antibiotic prescriptions 40% of all hospital acquired infections Significant burden
More informationProvincial Drugs & Therapeutics Committee Memorandum Version 2
Provincial Drugs & Therapeutics Committee Memorandum Version 2 16 Garfield Street 16, rue Garfield PO Box 2000, Charlottetown C.P. 2000, Charlottetown Prince Edward Island Île-du-Prince-Édouard Canada
More informationHealth PEI: Provincial Antibiotic Advisory Team Empiric Antibiotic Treatment Guidelines for Sepsis Syndromes in Adults
Health PEI: Provincial Antibiotic Advisory Team Empiric Antibiotic Treatment Guidelines for Sepsis Syndromes in Adults COMMUNITY-ACQUIRED PNEUMONIA HEALTHCARE-ASSOCIATED PNEUMONIA INTRA-ABDOMINAL INFECTION
More informationCONTAGIOUS COMMENTS Department of Epidemiology
VOLUME XXIX NUMBER 3 November 2014 CONTAGIOUS COMMENTS Department of Epidemiology Bugs and Drugs Elaine Dowell SM MLS (ASCP), Marti Roe SM MLS (ASCP), Sarah Parker MD, Jason Child PharmD, and Samuel R.
More informationCommunity Acquired Pneumonia: An Update on Guidelines
Community Acquired Pneumonia: An Update on Guidelines Claudia Summa, BScPhm Pharmacy Resident September 12, 2006 Objectives To give a brief description of the pathophysiology of community acquired pneumonia
More informationCellulitis. Assoc Prof Mark Thomas. Conference for General Practice Auckland Saturday 28 July 2018
Cellulitis Assoc Prof Mark Thomas Conference for General Practice Auckland Saturday 28 July 2018 Summary Cellulitis Usual treatment flucloxacillin for 5 days Frequent recurrences consider penicillin 250mg
More informationCopyright 2012 Diabetes In Control, Inc. For permission to reprint, please contact Heather Moran, Production Editor, at
Malignant Otitis Externa Inflammation and damage at the base of the skull due to an untreated outer ear P. aeruginosa most common organism Yellow-green drainage from the ear Odor Fever Deep inner ear pain
More informationCONTAGIOUS COMMENTS Department of Epidemiology
VOLUME XXXII NUMBER 6 September 2017 CONTAGIOUS COMMENTS Department of Epidemiology Bugs and Drugs Elaine Dowell SM MLS (ASCP), Stacey Hamilton MT SM (ASCP), Samuel Dominguez MD PhD, Sarah Parker MD, and
More informationSurgical infection ผ.ศ. น.พ. กำธร มำลำธรรม หน วยโรคต ดเช อ ภำคว ชำอำย รศำสตร คณะแพทยศำสตร โรงพยำบำลรำมำธ บด
Surgical infection ผ.ศ. น.พ. กำธร มำลำธรรม หน วยโรคต ดเช อ ภำคว ชำอำย รศำสตร คณะแพทยศำสตร โรงพยำบำลรำมำธ บด 1 Scope Surgical prophylaxis: Pharmacologic approach to prevent SSI Antimicrobial therapy for
More informationSuggestions for appropriate agents to include in routine antimicrobial susceptibility testing
Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing These suggestions are intended to indicate minimum sets of agents to test routinely in a diagnostic laboratory
More informationNecrotizing Soft Tissue Infections: Emerging Bacterial Resistance
Necrotizing Soft Tissue Infections: Emerging Bacterial Resistance Eileen M. Bulger, MD Professor of Surgery Harborview Medical Center University of Washington Objectives Review definition & diagnostic
More informationNational Clinical Guideline Centre Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults
National Clinical Guideline Centre Antibiotic classifications Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults Clinical guideline 191 Appendix N 3 December 2014
More informationجداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی
جداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی ویرایش دوم بر اساس ed., 2017 CLSI M100 27 th تابستان ۶۹۳۱ تهیه
More informationMedicinal Chemistry 561P. 2 st hour Examination. May 6, 2013 NAME: KEY. Good Luck!
Medicinal Chemistry 561P 2 st hour Examination May 6, 2013 NAME: KEY Good Luck! 2 MDCH 561P Exam 2 May 6, 2013 Name: KEY Grade: Fill in your scantron with the best choice for the questions below: 1. Which
More informationPharmacology Week 6 ANTIMICROBIAL AGENTS
Pharmacology Week 6 ANTIMICROBIAL AGENTS Mechanisms of antimicrobial action Mechanisms of antimicrobial action Bacteriostatic - Slow or stop bacterial growth, needs an immune system to finish off the microbe
More informationDeveloped by Kathy Wonderly RN, MSEd,CPHQ Developed: October 2009 Most recently updated: December 2014
Developed by Kathy Wonderly RN, MSEd,CPHQ Developed: October 2009 Most recently updated: December 2014 The Center for Medicare and Medicaid (CMS) is moving away from collecting data on the process of care
More informationGuidelines for the Initiation of Empirical Antibiotic therapy in Respiratory Disease (Adults)
Guidelines for the Initiation of Empirical Antibiotic therapy in Respiratory Disease (Adults) Community Acquired Pneumonia Community Acquired Pneumonia 1) Is it pneumonia? ie new symptoms and signs of
More informationVolume. December Infection. Notes. length of. cases as 90% 1 week. tonsillitis. First Line. sore throat / daily for 5 days. quinsy >4000.
Volume 8; Number 22 LINCOLNSHIRE GUIDELINES FOR THE TREATMENT OF COMMONLYY OCCURRING INFECTIONS IN PRIMARY CARE: WINTER 2014/15 In this issue of the PACE Bulletin we present an update of our Guidelines
More informationAntibiotics & Common Infections: Stewardship, Effectiveness, Safety & Clinical Pearls. Welcome We will begin shortly.
Antibiotics & Common Infections: Stewardship, Effectiveness, Safety & Clinical Pearls Welcome We will begin shortly. The Canadian Pharmacists Association is pleased to be collaborating with the following
More informationThis is the use of antibiotics before, during and after a diagnostic, therapeutic or surgical procedure to prevent infectious complications.
Antibiotic prophylaxis in surgery CSu2 Policy Antimicrobial prophylaxis is used to reduce the incidence of post operative wound infection; patients undergoing procedures associated with high infection
More informationAntimicrobial Prophylaxis in the Surgical Patient. M. J. Osgood
Antimicrobial Prophylaxis in the Surgical Patient M. J. Osgood Outline Definitions surgical site infection (SSI) Risk factors Wound classification Microbiology of SSIs Strategies for prevention of SSIs
More informationOBSTETRICS & GYNAECOLOGY. Penicillin G 5 million units IV ; followed by 2.5 million units 4hourly upto delivery
OBSTETRICS & GYNAECOLOGY A.OBSTETRICS Infection/Condition/likely organism Intrapartum Group B Streptococcal (GBS) infection; positive mothers Suggested treatment Preferred Penicillin G 5 million units
More information$100 $200 $300 $400 $500
Skin is In Runny Noses Got to go! Hear no evil It s in the Lungs $100 $100 $100 $100 $100 $200 $200 $200 $200 $200 $300 $300 $300 $300 $300 $400 $400 $400 $400 $400 $500 $500 $500 $500 $500 Double Jeopardy
More informationAntimicrobial Pharmacodynamics
Antimicrobial Pharmacodynamics November 28, 2007 George P. Allen, Pharm.D. Assistant Professor, Pharmacy Practice OSU College of Pharmacy at OHSU Objectives Become familiar with PD parameters what they
More informationRoutine internal quality control as recommended by EUCAST Version 3.1, valid from
Routine internal quality control as recommended by EUCAST Version.1, valid from 01-01-01 Escherichia coli Pseudomonas aeruginosa Staphylococcus aureus Enterococcus faecalis Streptococcus pneumoniae Haemophilus
More informationWhat is pneumonia? Infection of the lung parenchyma Causative agents include bacteria, viruses, fungi, protozoa.
Pneumonia What is pneumonia? Infection of the lung parenchyma Causative agents include bacteria, viruses, fungi, protozoa www.netmedicine.com/xray/xr.htm Definition acute infectious disease, etiology usually
More informationIntrinsic, implied and default resistance
Appendix A Intrinsic, implied and default resistance Magiorakos et al. [1] and CLSI [2] are our primary sources of information on intrinsic resistance. Sanford et al. [3] and Gilbert et al. [4] have been
More informationPneumonia considerations Galia Rahav Infectious diseases unit Sheba medical center
Pneumonia considerations 2017 Galia Rahav Infectious diseases unit Sheba medical center Sir William Osler (1849 1919) "Father of modern medicine Pneumonia: The old man's friend The captain of the men of
More informationPrinciples of Antimicrobial Therapy
Principles of Antimicrobial Therapy Doo Ryeon Chung, MD, PhD Professor of Medicine, Division of Infectious Diseases Director, Infection Control Office SUNGKYUNKWAN UNIVERSITY SCHOOL OF MEDICINE CASE 1
More informationConcise Antibiogram Toolkit Background
Background This toolkit is designed to guide nursing homes in creating their own antibiograms, an important tool for guiding empiric antimicrobial therapy. Information about antibiograms and instructions
More informationInfection Prevention Highlights for the Medical Staff. Pamela Rohrbach MSN, RN, CIC Director of Infection Prevention
Highlights for the Medical Staff Pamela Rohrbach MSN, RN, CIC Director of Infection Prevention Standard Precautions every patient every time a. Hand Hygiene b. Use of Personal Protective Equipment (PPE)
More informationTreatment of Respiratory Tract Infections Prof. Mohammad Alhumayyd Dr. Aliah Alshanwani
Treatment of Respiratory Tract Infections Prof. Mohammad Alhumayyd Dr. Aliah Alshanwani 30-1-2018 1 Objectives of the lecture At the end of lecture, the students should be able to understand the following:
More informationInPHARMation. Pharmacy and Therapeutics Committee Update May 23 rd, 2018 Meeting
VOLUME FOUR; ISSUE 5 May 23, 2018 Edited by: Gregory K. Perry, PharmD, BCPS-AQID InPHARMation Pharmacy and Therapeutics Committee Update May 23 rd, 2018 Meeting The Pharmacy and Therapeutics Committee
More informationEinheit für pädiatrische Infektiologie Antibiotics - what, why, when and how?
Einheit für pädiatrische Infektiologie Antibiotics - what, why, when and how? Andrea Duppenthaler andrea.duppenthaler@insel.ch Limping patient local pain swelling tenderness warmth fever acute Osteomyelitis
More informationSuper Bugs and Wonder Drugs: Protecting the One While Respecting the Many
Super Bugs and Wonder Drugs: Protecting the One While Respecting the Many Vicki Stringfellow, MSN, CPNP-AC/PC Werner Division of Pediatric Critical Care University of Kentucky Lexington, KY Disclosure
More informationSimilar to Penicillins: -Chemically. -Mechanism of action. -Toxicity.
Similar to Penicillins: -Chemically. -Mechanism of action. -Toxicity. Cephalosporins are divided into Generations: -First generation have better activity against gram positive organisms. -Later compounds
More informationAntimicrobial susceptibility
Antimicrobial susceptibility PATTERNS Microbiology Department Canterbury ealth Laboratories and Clinical Pharmacology Department Canterbury District ealth Board March 2011 Contents Preface... Page 1 ANTIMICROBIAL
More information2012 ANTIBIOGRAM. Central Zone Former DTHR Sites. Department of Pathology and Laboratory Medicine
2012 ANTIBIOGRAM Central Zone Former DTHR Sites Department of Pathology and Laboratory Medicine Medically Relevant Pathogens Based on Gram Morphology Gram-negative Bacilli Lactose Fermenters Non-lactose
More informationStanding Orders for the Treatment of Outpatient Peritonitis
Standing Orders for the Treatment of Outpatient Peritonitis 1. Definition of Peritonitis: a. Cloudy effluent. b. WBC > 100 cells/mm3 with >50% polymorphonuclear (PMN) cells with minimum 2 hour dwell. c.
More informationAntibiotic Usage Guidelines in Hospital
SUPPLEMENT TO JAPI december VOL. 58 51 Antibiotic Usage Guidelines in Hospital Camilla Rodrigues * Use of surveillance data information of Hospital antibiotic policy guidelines from Hinduja Hospital. The
More informationEuropean Committee on Antimicrobial Susceptibility Testing
European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control as recommended by EUCAST Version 5.0, valid from 015-01-09 This document should be cited as "The
More informationSHC Surgical Antimicrobial Prophylaxis Guidelines
SHC Surgical Antimicrobial Prophylaxis Guidelines I. Purpose/Background This document is based upon the 2013 consensus guidelines from American Society of Health-System Pharmacists (ASHP), the Infectious
More informationPneumonia. Community Acquired Pneumonia (CAP): definition. At least 2 new symptoms
Pneumonia Lisa G. Winston, MD University of California, San Francisco San Francisco General Hospital Community Acquired Pneumonia (CAP): definition At least 2 new symptoms Fever or hypothermia Cough Rigors
More informationCentral Nervous System Infections
Central Nervous System Infections Meningitis Treatment Bacterial meningitis is a MEDICAL EMERGENCY. ANTIBIOTICS SHOULD BE STARTED AS SOON AS THE POSSIBILITY OF BACTERIAL MENINGITIS BECOMES EVIDENT, IDEALLY
More information** the doctor start the lecture with revising some information from the last one:
Page 1 of 7 ** the doctor start the lecture with revising some information from the last one: #penicillin G has a good susceptibility against gram(+ve), Neisseria (-ve) #mostly active against strep. (don
More informationEuropean Committee on Antimicrobial Susceptibility Testing
European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control for MIC determination and disk diffusion as recommended by EUCAST Version 8.0, valid from 018-01-01
More informationNorthwestern Medicine Central DuPage Hospital Antimicrobial Criteria Updated 11/16/16
Northwestern Medicine Central DuPage Hospital Antimicrobial Criteria Updated 11/16/16 These criteria are based on national and local susceptibility data as well as Infectious Disease Society of America
More informationPIPERACILLIN- TAZOBACTAM INJECTION - SUPPLY PROBLEMS
PIPERACILLIN- TAZOBACTAM INJECTION - SUPPLY PROBLEMS The current supply of piperacillin- tazobactam should be reserved f Microbiology / Infectious Diseases approval and f neutropenic sepsis, severe sepsis
More information